COc1ccc(OC)c(CNS(=O)(=O)c2c(C(=O)N3CCC(C)CC3)c(C)n(C)c2C)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?